US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 26, 2021 (6 years ago)

Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)

What was recalled

Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by: Alvogen, Inc. Pine Brook, NJ 07058 USA, NDC 47781-355-03

Recalling firm
Alvogen, Inc
NDC code
47781-355-03
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0649-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Pine recalls

See all